Targeting host factors to circumvent anti-malarial drug resistance.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current pharmaceutical design

• Publication date

  2012-12-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138161213804070276PMID 22973886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relevance of host genes in malaria.

  2018influential reference
• Liver-stage malaria parasites vulnerable to diverse chemical scaffolds

  2012cited by this paper
• Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug

  2012cited by this paper
• Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo

  2012cited by this paper
• Host-mediated regulation of superinfection in malaria

  2011cited by this paper
• Vivax malaria in Mauritania includes infection of a Duffy-negative individual

  2011cited by this paper
• MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR

  2011cited by this paper
• Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization

  2011cited by this paper
• Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors.

  2011cited by this paper
• Malaria in pregnancy: small babies, big problem.

  2011cited by this paper
• Faculty Opinions recommendation of Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

  2011influential reference
• Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development

  2011cited by this paper
• Superinfection in malaria: Plasmodium shows its iron will

  2011cited by this paper
• A Novel Carbon Monoxide-Releasing Molecule Fully Protects Mice from Severe Malaria

  2011cited by this paper
• Antivirals: Achilles heel of Ebola viral entry

  2011cited by this paper
• BASIGIN is a receptor essential for erythrocyte invasion by Plasmodium falciparum

  2011cited by this paper
• Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

  2011cited by this paper
• Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

  2011cited by this paper
• Small molecule inhibitors reveal Niemann-Pick C1 is essential for ebolavirus infection

  2011cited by this paper
• Design and Immunogenicity of a Novel Synthetic Antigen Based on the Ligand Domain of the Plasmodium vivax Duffy Binding Protein

  2011cited by this paper
• Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

  2011cited by this paper
• The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species

  2011influential reference
• Hepatitis C virus entry and the tetraspanin CD81.

  2011cited by this paper
• Early Transcriptional Responses of HepG2-A16 Liver Cells to Infection by Plasmodium falciparum Sporozoites*

  2011cited by this paper
• Duffy Negative Antigen Is No Longer a Barrier to Plasmodium vivax – Molecular Evidences from the African West Coast (Angola and Equatorial Guinea)

  2011cited by this paper
• Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria.

  2011cited by this paper
• VEGF Promotes Malaria-Associated Acute Lung Injury in Mice

  2010influential reference
• Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

  2010cited by this paper
• Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria

  2010cited by this paper
• Transcriptional Activity of Plasmodium Subtilisin-like Protease 2 (Pf-Sub2) 5'Untranslated Regions and Its Interaction with Hepatocyte Growth Factor

  2010cited by this paper
• Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand

  2010cited by this paper
• Transforming Growth Factor Beta 2 and Heme Oxygenase 1 Genes Are Risk Factors for the Cerebral Malaria Syndrome in Angolan Children

  2010cited by this paper
• Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people

  2010cited by this paper
• Sequestration and Tissue Accumulation of Human Malaria Parasites: Can We Learn Anything from Rodent Models of Malaria?

  2010cited by this paper
• Var gene expression and human Plasmodium pathogenesis.

  2010cited by this paper
• The struggle for iron – a metal at the host–pathogen interface

  2010cited by this paper
• Heme oxygenase-1 affords protection against noncerebral forms of severe malaria

  2009cited by this paper
• Cerebral malaria and the hemolysis/methemoglobin/heme hypothesis: shedding new light on an old disease.

  2009cited by this paper
• The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment‐naïve hepatitis C patients

  2009cited by this paper
• Plasmodium falciparum infected erythrocytes induce hepcidin (HAMP) mRNA synthesis by peripheral blood mononuclear cells

  2009cited by this paper
• Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum.

  2009cited by this paper
• Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

  2009cited by this paper
• Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events

  2009influential reference
• Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1

  2009cited by this paper
• Identification of Drosophila Mutants Altering Defense of and Endurance to Listeria monocytogenes Infection

  2008cited by this paper
• Kinome-Wide RNAi Screen Implicates at Least 5 Host Hepatocyte Kinases in Plasmodium Sporozoite Infection

  2008cited by this paper
• Placental hypoxia during placental malaria.

  2008cited by this paper
• Genistein-Supplemented Diet Decreases Malaria Liver Infection in Mice and Constitutes a Potential Prophylactic Strategy

  2008influential reference
• The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent

  2008cited by this paper
• Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors

  2008cited by this paper
• Hepatocyte Permissiveness to Plasmodium Infection Is Conveyed by a Short and Structurally Conserved Region of the CD81 Large Extracellular Domain

  2008cited by this paper
• MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

  2008cited by this paper
• Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection.

  2008cited by this paper
• Potent Synergistic Anti-Human Immunodeficiency Virus (HIV) Effects Using Combinations of the CCR5 Inhibitor Aplaviroc with Other Anti-HIV Drugs

  2008cited by this paper
• Natural selection of FLT1 alleles and their association with malaria resistance in utero

  2008cited by this paper
• Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.

  2008cited by this paper
• Crystal Structure of Soluble Domain of Malaria Sporozoite Protein UIS3 in Complex with Lipid

  2008cited by this paper
• Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection.

  2008influential reference
• Iron‐depletion limits intracellular bacterial growth in macrophages

  2008cited by this paper
• Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection.

  2008influential reference
• Glucosidase inhibitors as antiviral agents for hepatitis B and C.

  2007cited by this paper
• RNAi Screen in Drosophila Cells Reveals the Involvement of the Tom Complex in Chlamydia Infection

  2007cited by this paper
• Severe malaria increases the list of heme oxygenase-1-protected diseases.

  2007cited by this paper
• Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells.

  2007cited by this paper
• The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity.

  2007cited by this paper
• Evaluation of a cyclophilin inhibitor in hepatitis C virus–infected chimeric mice in vivo

  2007cited by this paper
• Alternative invasion pathways for Plasmodium berghei sporozoites.

  2007cited by this paper
• Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria

  2007cited by this paper
• L-FABP is a critical host factor for successful malaria liver stage development.

  2007cited by this paper
• Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1

  2007cited by this paper
• New HIV drug classes on the horizon

  2007cited by this paper
• HIV entry inhibitors.

  2007cited by this paper
• Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species

  2006cited by this paper
• Invasion of red blood cells by malaria parasites.

  2006cited by this paper
• Quorum-sensing inhibitors as anti-pathogenic drugs.

  2006cited by this paper
• Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites

  2006cited by this paper
• miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.

  2006cited by this paper
• The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitro

  2006cited by this paper
• Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway

  2006cited by this paper
• Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial.

  2006cited by this paper
• Hypertension and Maternal–Fetal Conflict during Placental Malaria

  2006cited by this paper
• Genome-Wide RNAi Screen for Host Factors Required for Intracellular Bacterial Infection

  2005cited by this paper
• Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA

  2005cited by this paper
• Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar.

  2005cited by this paper
• How malaria has affected the human genome and what human genetics can teach us about malaria.

  2005cited by this paper
• Molecular Mechanism for Switching of P. falciparum Invasion Pathways into Human Erythrocytes

  2005cited by this paper
• Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

  2005cited by this paper
• Use of RNA interference in Drosophila S2 cells to identify host pathways controlling compartmentalization of an intracellular pathogen.

  2005cited by this paper
• Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration.

  2005cited by this paper
• Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.

  2005cited by this paper
• Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

  2005cited by this paper
• Pathogenesis of Malaria and Clinically Similar Conditions

  2004cited by this paper
• Clinical features and pathogenesis of severe malaria.

  2004cited by this paper
• Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.

  2004cited by this paper
• Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

  2004cited by this paper
• Interruption of the blood-stage cycle of the malaria parasite, Plasmodium chabaudi, by protein tyrosine kinase inhibitors.

  2003cited by this paper
• CD36 and malaria: friends or foes?

  2003cited by this paper
• The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.

  2003cited by this paper
• Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity

  2003cited by this paper
• Hepatocyte growth factor and its receptor are required for malaria infection

  2003cited by this paper

• Inhibition of malaria and babesiosis parasites by putative red blood cell targeting small molecules

  2024cites this paper
• Towards next-generation treatment options to combat Plasmodium falciparum malaria

  2024cites this paper
• Pharmacology of Manilkara hexandra leaf extract: potent antimalarial by targeting β-hematin formation and pro-inflammatory cytokine investigation

  2024cites this paper
• Human nuclear hormone receptor activity contributes to malaria parasite liver stage development.

  2023cites this paper
• Role of Host Small GTPases in Apicomplexan Parasite Infection

  2022cites this paper
• In Vitro Antimalarial Activity of Inhibitors of the Human GTPase Rac1

  2021cites this paper
• Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin

  2021cites this paper
• Targeting Host Glycolysis as a Strategy for Antimalarial Development

  2021cites this paper
• Host-targeted Interventions as an Exciting Opportunity to Combat Malaria.

  2021cites this paper
• Host-directed therapy, an untapped opportunity for antimalarial intervention

  2021cites this paper
• Accelerated erythrocyte senescence causes dose-limiting anemia of antimalarial enolase inhibitors

  2020cites this paper
• Repurposing Drugs to Fight Hepatic Malaria Parasites

  2020cites this paper
• Characterization of the erythrocyte GTPase Rac1 in relation to Plasmodium falciparum invasion

  2020cites this paper
• Targeting liver stage malaria with metformin.

  2019cites this paper
• Discovery of Druggable Host Factors Critical to Plasmodium Liver-Stage Infection.

  2019cites this paper
• Targeting of host cell receptor tyrosine kinases by intracellular pathogens

  2019cites this paper
• Opportunities for Host-targeted Therapies for Malaria.

  2018cites this paper
• Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites

  2018cites this paper
• Plasmodial Kinase Inhibitors: License to Cure?

  2018cites this paper
• Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infection

  2018cites this paper
• Metabolomic changes in vertebrate host during malaria disease progression

  2018cites this paper
• Resisting resistance: is there a solution for malaria?

  2016cites this paper
• Asiatic acid influences parasitaemia reduction and ameliorates malaria anaemia in P. berghei infected Sprague–Dawley male rats

  2016cites this paper
• Battling Drug Resistance: A Tale of Two Pathogens

  2016cites this paper
• Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites.

  2015cites this paper
• Basigin is a druggable target for host-oriented antimalarial interventions

  2015cites this paper
• Chemical Derivatives of a Small Molecule Deubiquitinase Inhibitor Have Antiviral Activity against Several RNA Viruses

  2014cites this paper
• Antiparasitic chemotherapy: from genomes to mechanisms.

  2014cites this paper
• Treatment of Erythrocytes with the 2-Cys Peroxiredoxin Inhibitor, Conoidin A, Prevents the Growth of Plasmodium falciparum and Enhances Parasite Sensitivity to Chloroquine

  2014cites this paper
• Anti-disease therapy for malaria: 'resistance proof'?

  2012cites this paper
• Editorial: antimalarial drug discovery and design in the era of resistance.

  2012cites this paper